Inventiva (IVA) Preferred Stock Liabilities (2023 - 2025)
Inventiva's (IVA) quarterly Preferred Stock Liabilities came in at $945186.3 in Q2 2025, down 22.4% year-on-year from $1.2 million in Q2 2024, and down 22.34% quarter-over-quarter from $1.2 million in Q4 2024.
Inventiva (IVA) Preferred Stock Liabilities (2023 - 2025) Analysis & Trends
Inventiva's Preferred Stock Liabilities history runs 3 years deep, the most recent figure standing at $945186.3 for Q2 2025.
- On a quarterly basis, Preferred Stock Liabilities fell 22.4% year-over-year to $945186.3 in Q2 2025; TTM through Jun 2025 was $945186.3, a 22.4% decrease from a year earlier, with the FY2024 full-year figure at $1.2 million, down 20.62% from the prior year.
- Preferred Stock Liabilities retreated to $945186.3 in Q2 2025 per IVA's latest filing, from $1.2 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $1.5 million in Q4 2023 and bottomed at $945186.3 in Q2 2025.
- The 3-year median for Preferred Stock Liabilities is $1.2 million (2024), against an average of $1.2 million.
- Across the five-year window, Preferred Stock Liabilities declined 20.62% in 2024 and declined 22.4% in 2025, its largest moves.
- Year by year, Preferred Stock Liabilities stood at $1.5 million in 2023, then decreased by 20.62% to $1.2 million in 2024, then retreated by 22.34% to $945186.3 in 2025.
- Per Business Quant, the three latest IVA Preferred Stock Liabilities figures stand at $945186.3 (Q2 2025), $1.2 million (Q4 2024), and $1.2 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 945,186.34 |
| Dec 31, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.53 Mn |